Cancer therapies, healing, and society.

Visit Cancer Commentary

The Pathwork Tissue Of Origin Test: Received FDA Clearance

Posted on July 31, 2008

Pathwork Diagnostics, Inc. recently announced that its Pathwork Tissue of Origin Test for use in hard-to-identify-tumors has been cleared by the FDA.The test analyzes a tumor s gene expression pattern to help pinpoint the source of hard-to-identify tumors and is the first test of its kind to receive FDA clearance.Up to an estimated 200,000 newly diagnosed cancer patients annually in the U.S. may have a tumor for which the site of origin is uncertain after the initial diagnostic workup.The FDA s clearance underscores the growing role that patients genomic information can play in helpin...

Original article link


cancer , tumor